IP Library › Granted Patent US 9,057,063
Granted Patent B2
US 9,057,063 · App. 12/596,345 · Granted Jun 16, 2015

Genetically modified biological cells

Inventor: Theresa O'Keefe (Waltham, MA)
Assignee: Theresa O'Keefe
C12N15/03C12P19/42C12N2500/38C07K14/195C12N15/70C12N15/74
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,057,063
App. No.
12/596,345
Granted
Jun 16, 2015
Kind
B2
Abstract

The present invention is based, in part, on our discovery of a way to configure expression cassettes so that the expression of a selectable marker protein, which is critical for the growth or survival of a cell, also results in the expression of a protein of interest in a biological cell. Accordingly, in one aspect, the invention features a genetically modified cell (e.g., a bacterial cell) that includes a chromosomally integrated or cytoplasmic expression cassette that includes a first nucleic acid sequence encoding a protein of interest and a second nucleic acid sequence encoding a selectable marker protein. The regulatory sequence (e.g., the sequence encoding a functional promoter) that drives expression of the required selectable marker protein also drives expression of the protein of interest. For that reason, we may refer to their expression as being “linked” or “functionally couple.”

Claims (12)

1. A recombinant genetically modified bacterial cell comprising:

a recombinant chromosomally integrated expression cassette, the recombinant chromosomally integrated expression cassette comprising a first nucleic acid molecule encoding a protein of interest and a second nucleic acid molecule encoding a positive selectable marker, said positive selectable marker being an enzyme necessary for the production of an essential vitamin B12, which is the enzyme with EC 1.3.1.54 or EC 2.1.1.133, wherein the expression of the positive selectable marker is necessary for survival of the genetically modified bacterial cell in media lacking said vitamin, and wherein promoter of the expression cassette drives expression of positive selectable marker and expression of the protein of interest.

2. The recombinant genetically modified bacterial cell of claim 1 , wherein the cell is a cyanobacterium.

3. The recombinant genetically modified bacterial cell of claim 2 , wherein the cyanobacterium is Anabaena species (sp), Anabaenopsis sp, Aphanizomenon sp, Arthrospira sp, Calothrix sp, Chamaesiphon sp, Chlorogloeopsis sp, Chroococcidiopsis sp, Chroococcus sp, Cyanothece sp, Cylindrospermum sp, Dactylococcopsis sp, Dermocarpella sp, Fischerella sp, Geitlerinema sp, Gloeobacter sp, Gloeocapsa sp, Gloeothece sp, Leptolyngbya sp, Lyngbya sp, Microchaete sp, Microcoleus sp, Microcystis sp, Myxosarcina sp, Nodularia sp, Nostoc sp, Oscillatoria sp, Pleurocapsa sp, Pseudanabaena sp, Scytonema sp, Spirulina sp, Stanieria sp, Symploca sp, Synechococcus sp, Synechocystis sp, Tolypothrix sp, or Xenococcus sp.

4. The recombinant genetically modified bacterial cell of claim 1 , wherein the protein of interest is a metal-binding protein.

5. The recombinant genetically modified bacterial cell of claim 4 , wherein the metal-binding protein is selected from the group consisting of a metallothionein and a transcription factor.

6. The recombinant genetically modified bacterial cell of claim 1 , wherein the protein of interest is a protease, an oxidase, a phytase, a chitinase, an invertase, a lipase, a cellulase, a xylenase, a kinase, or a phosphatase.

7. The recombinant genetically modified bacterial cell of claim 1 , wherein the enzyme is pyruvate dehydrogenase, dihydrolipoyl dehydrogenase, dihydrolipoyllysine-residue acetyltransferase, acteyl-CoA carboxylase, malonyl-CoA:ACP transacylase or fatty acid synthase.

8. The recombinant genetically modified bacterial cell of claim 1 , wherein the recombinant expression cassette further comprises a nucleic acid molecule encoding a purification tag operatively coupled to the first nucleic acid molecule.

9. The recombinant genetically modified bacterial cell of claim 1 , wherein the recombinant expression cassette further comprises a nucleic acid molecule encoding a linker between the protein of interest and the selectable marker protein, wherein said linker acts as a hinge and wherein said protein of interest and the selectable marker enzyme retain biological activity.

10. The recombinant genetically modified bacterial cell of claim 1 , wherein the protein of interest is a lipase.

11. A kit comprising the bacterial cell of claim 1 and instructional materials.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2012
From: WALTHAM TECHNOLOGIES INC
To: O'KEEFE, THERESA
Reel/Frame 028862/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2009
From: O'KEEFE, THERESA; CURTISS, TIMOTHY J.
To: WALTHAM TECHNOLOGIES, INC.
Reel/Frame 023619/0264 →
Continuity (3)
Provisional Application 60913043 · Apr 20, 2007
Provisional Application 60947757 · Jul 3, 2007
Related Publication 20100304432A1 · Dec 2, 2010